22nd Century Assets & Liabilities Overview 2011-2023 | XXII

22nd Century assets & liabilities overview from 2011 to 2023. Assets & liabilities overview can be defined as overview of the balance sheet showing the primary categories of assets, liabilities and equity in a single chart.
22nd Century Annual Assets & Liabilities Overview
(Millions of US $)
22nd Century Quarterly Assets & Liabilities Overview
(Millions of US $)
Sector Industry Market Cap Revenue
Consumer Staples Tobacco Products $0.006B $0.032B
22nd Century Group, Inc. is a plant biotechnology company focused on decreasing/increasing the level of nicotine in the tobacco plant through genetic engineering and breeding. The Company is focused on development of smoking cessation aid and owns and controls several patents. The company's products include X-22, a prescription smoking cessation aid, which is a tobacco-based botanical medical product for use as a smoking cessation therapy. 22nd Century Group, Inc. is based in Williamsville, New York.
Stock Name Country Market Cap PE Ratio
Philip Morris (PM) United States $149.315B 15.67
Altria (MO) United States $75.266B 8.91
British American Tobacco (BTI) United Kingdom $65.673B 0.00
Imperial Tobacco Group (IMBBY) United Kingdom $20.075B 0.00
Universal (UVV) United States $1.283B 12.25
Turning Point Brands (TPB) United States $0.516B 10.69